Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Rheumatoid arthritis

The benefits of early treatment after decades

Early, targeted treatment improves the outcome of rheumatoid arthritis, reducing disease-associated disability and mortality. Until now, it was unknown whether these beneficial effects extended beyond 10 years following initial therapy. Could these effects persist even after 20 years?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann. Rheum. Dis. 76, 960–977 (2017).

    Article  Google Scholar 

  2. Smolen, J. S. et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 69, 631–637 (2010).

    Article  Google Scholar 

  3. Cush, J. J. Early rheumatoid arthritis — is there a window of opportunity? J. Rheumatol. Suppl. 80, 1–7 (2007).

    CAS  PubMed  Google Scholar 

  4. Daien, C. I., Hua, C., Combe, B. & Landewe, R. Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis. RMD Open 3, e000404 (2017).

    Article  Google Scholar 

  5. Gwinnutt, J. M. et al. The 20 year outcome and association between early treatment and mortality and disability in an inception cohort of patients with rheumatoid arthritis: results from the Norfolk Arthritis register. Arthritis Rheumatol. http://dx.doi.org/10.1002/art.40090 (2017).

  6. O'Dell, J. R. in Kelley's Textbook of Rheumatology 9th edn Ch. 71 1137–1160 (Elsevier Saunders, 2013).

    Book  Google Scholar 

  7. Mian, A. N. et al. Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies. BMC Musculoskelet. Disord. 17, 44 (2016).

    Article  Google Scholar 

  8. Andersson, M. L., Forslind, K. & Hafström, I. Patients with early rheumatoid arthritis in the 2000s have equal disability and pain despite less disease activity compared with the 1990s: data from the BARFOT Study over 8 years. J. Rheumatol. 44, 723–731 (2017).

    Article  CAS  Google Scholar 

  9. Myasoedova, E. et al. Decreased cardiovascular mortality in patients with incident rheumatoid arthritis (RA) in recent years: dawn of a new era in cardiovascular disease in RA? J. Rheumatol. 44, 732–739 (2017).

    Article  Google Scholar 

  10. Kiadaliri, A. A., Felson, D. T., Neogi, T. & Englund, M. Rheumatoid arthritis as underlying cause of death in 31 countries, 1987-2011: trend analysis of WHO mortality database. Arthritis Rheumatol. http://dx.doi.org/10.1002/art.40091 (2017).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angela Zink.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zink, A., Albrecht, K. The benefits of early treatment after decades. Nat Rev Rheumatol 13, 458–459 (2017). https://doi.org/10.1038/nrrheum.2017.104

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2017.104

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing